Trump-backed cannabis rescheduling to Schedule III could expand FDA-style trials for cannabinoid drugs and shift advantages toward pharma and larger firms. 

LITTLE ROCK, Ark. (KATV) — A major shift in U.S. drug policy may be on the horizon. President Donald Trump is expected to sign an executive order directing his cabinet to reclassify marijuana under federal law, moving it from Schedule I, the strictest category, to Schedule III. If enacted, this would mark one of the...

Cannabis stocks jumped Friday as reports emerged that the White House is preparing to ease federal restrictions on marijuana. Some shares soared more than 50 percent on the news that President Trum…